Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP1941 and glimepiride drug-drug interaction crossover study in healthy adults
NL-OMON34715Active, not recruiting
- Sponsor
- Astellas Pharma
- Start
- Jan 2010
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ipragliflozin and glimepiride in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Astellas Pharma. Primary endpoints: Glimepiride pharmacokinetics with and without ASP1941, ASP1941 pharmacokinetics with and without glimepiride and 2 more. Started Jan 2010; status: active, not recruiting.
02
Drugs
ipragliflozinglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON34715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34715.